Healthtech Startups

Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases. The biotech company focuses on targeting the underlying biology of disease to change the standard of care for patients.

5 investors

UserWay develops digital accessibility solutions to make web and digital content compliant with accessibility standards and usable by people with disabilities. The company serves enterprises and website owners seeking to ensure their digital properties are accessible to all users.

5 investors

Validic operates a health IoT platform that connects over 700 medical devices and health apps to health systems, health plans, and life sciences organizations for clinical use. The company integrates siloed personal health data into actionable clinical workflows.

5 investors

Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery. The company has advanced lead programs in Parkinson's disease and lupus through Phase 2 clinical trials.

5 investors

VIDA provides AI-powered imaging biomarkers and clinical trial imaging services for life-sciences sponsors, built on its VIDA Intelligence Platform to collect and analyze imaging data across drug development and trials. Its quantitative imaging covers respiratory, cardiovascular, oncology, neurology, musculoskeletal, and gastroenterology therapeutic areas, along with digital biobank capabilities.

5 investors

ViewsML applies AI to support the development and delivery of precision medicines, including virtual IHC technology for pathology. It operates in the AI-driven healthcare and diagnostics space.

5 investors

Vira Health provides digital clinical care and support services for women's and men's health across all life stages, partnering with healthcare systems and employers.

5 investors

Visibly operates a vision testing platform and network of licensed eye care providers that enable telehealth vision care services and prescription renewals. The platform serves retailers, ecommerce sites, and other customer-facing businesses seeking to offer at-home or onsite eye care consultations, prescription verification, and contact lens compliance automation.

5 investors

Vitrue Health provides personalized healthcare pathways to help stabilize healthcare costs, focusing on musculoskeletal pain management. The platform serves employee wellness and workplace health markets.

5 investors

Vocxi Health develops MyBreathPrint, a noninvasive breath-analysis system that uses a sensor array to detect volatile organic compounds at parts-per-billion levels and connect them to disease patterns, with an initial focus on early lung cancer detection. Results are uploaded to a cloud platform and delivered to a physician for analysis, intended for use in doctors' offices and eventually at home.

5 investors

Voiceitt provides real-time captioning for Microsoft Teams that supports non-standard speakers, including people with speech disabilities, Deaf individuals, and those with accented English. The company builds voice AI technology to make speech recognition accessible to underrepresented speaker populations.

5 investors

Volastra Therapeutics is a drug discovery and development company working on novel cancer therapies. Its team spans drug discovery, clinical development, and business strategy to bring new oncology treatments to patients.

5 investors

Waymark builds an AI-powered clinic model for Medicaid populations, using predictive analytics and clinical decision support to identify at-risk patients and coordinate community-based care. The company works with health plans and health systems to improve health outcomes and reduce costs for underinsured populations.

5 investors

Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions. The company serves healthcare providers, health plans, and patients seeking evidence-based, technology-enabled chronic care management.

5 investors

Wellth helps individuals with chronic diseases develop positive behavioral habits that improve health outcomes and quality of life. The company serves D-SNP plans and the chronic disease management market.

5 investors

Zerigo Health develops technology-driven digital therapeutics and care solutions for individuals living with chronic skin conditions. It combines device-based and data-driven approaches to support patient-centered care.

5 investors

Wellumio develops axana®, a portable, energy-efficient MRI system based on its Pulsed Gradient Free Mapping (PGFM) technology, designed to detect acute stroke quickly in front-line care settings. The product targets stroke diagnostics and brain imaging workflows in medical and critical care environments.

5 investors

Wheel is a virtual care platform that enables healthcare organizations and consumer health brands to deliver remote patient care through a configurable infrastructure and network of clinicians.

5 investors

Windward Bio is a clinical-stage biotechnology company developing long-acting monoclonal and bispecific antibodies for serious immunological conditions such as asthma, COPD, and dermatological diseases. Its lead program WIN378 is an ultra long-acting anti-TSLP antibody in a Phase 2/3 asthma trial and Phase 2 COPD study, with a broader pipeline including the anti-TSLPxIL-13 bispecific WIN027.

5 investors

Xandar Kardian uses ultra-wideband (UWB) radar sensors to monitor human vital signs and building occupancy, serving healthcare providers for continuous, contactless vital signs monitoring and building owners and operators for real-time occupancy data and people counting. The company operates in health monitoring and property technology.

5 investors

XII Medical develops neuromodulation therapies for treating obstructive sleep apnea, focusing on simplifying treatment options and improving patient outcomes.

5 investors

Yana is a mobile app offering a supportive companion for emotional wellbeing and self-reflection, used by consumers seeking emotional support. It is positioned as a complement to, not a substitute for, professional mental health care.

5 investors

YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production. The company targets men seeking an alternative to condoms or vasectomy.

5 investors

YourPath provides mental health counseling, substance use disorder treatment, peer support, and telehealth services, including on-demand assessments, individual therapy, and group sessions. It serves individuals dealing with stress, anxiety, depression, and substance use, with services available in Kentucky.

5 investors